Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Tissue Engineering for Craniofacial Reconstruction

By HospiMedica staff writers
Posted on 10 Apr 2007
Tissue engineering has emerged as a promising option for the reconstitution of lost or damaged organs and tissues, avoiding the complications associated with traditional transplants.

Tissue engineers attempt to repair or regenerate damaged tissue by using engineered tissue replacements that can maintain functionality during regeneration and ultimately integrate into the host tissue.

The conventional tissue-engineering prototype combines isolated cells with suitable bioactive agents in a biomaterial scaffold. More...
It is widely recognized that scaffold architecture can deeply influence the behavior of cells on tissue-engineering constructs.

During the 85th General Session of the International Association for Dental Research, held in March 2007 in New Orleans, LA, USA, scientists from the University of Durham (UK) presented their study's findings reporting on high internal phase emulsion (HIPE) polymerization, which offers tremendous control of scaffold morphology.

HIPEs can be readily molded into the irregular shapes frequently needed in craniofacial reconstruction and cured in situ to a rigid foam. The investigators demonstrated that emulsion templating could be used to generate rigid, biodegradable scaffolds with interconnected pores. These scaffolds are of particular interest in craniofacial tissue engineering, because of the rigidity of the resulting foams and the ease of fabrication.


Related Links:
University of Durham

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Endoscopy Display
E190
Bipolar Coagulation Generator
Aesculap
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.